Jeffrey S. Wefel, Ph.D.
Affiliations: | 2002 | University of Houston, Houston, TX, United States |
Area:
Alzheimer's diseaseGoogle:
"Jeffrey Wefel"Mean distance: 17.91 (cluster 30) | S | N | B | C | P |
Parents
Sign in to add mentorPaul J. Massman | grad student | 2002 | University of Houston | |
(Psychoneuroendocrinology in breast cancer: The effect of adjuvant tamoxifen therapy on cognitive and emotional functioning in women with early breast cancer.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Cowan BA, Olivier K, Tombal B, et al. (2023) Treatment-Related Cognitive Impairment in Patients with Prostate Cancer: Patients' Real-World Insights for Optimizing Outcomes. Advances in Therapy |
Gondi V, Deshmukh S, Brown PD, et al. (2023) Sustained Preservation of Cognition and Prevention of Patient-Reported Symptoms with Hippocampal Avoidance during Whole-Brain Radiotherapy for Brain Metastases: Final Results of NRG Oncology CC001. International Journal of Radiation Oncology, Biology, Physics |
Guran E, Hu J, Wefel JS, et al. (2022) Perioperative considerations in patients with chemotherapy-induced cognitive impairment: a narrative review. British Journal of Anaesthesia |
Wefel JS, Woods SP. (2022) Measuring everyday functioning in patients with brain tumor: The long rows yet to hoe. Neuro-Oncology Practice. 9: 253-254 |
Lehrer EJ, Jones BM, Dickstein DR, et al. (2022) The Cognitive Effects of Radiotherapy for Brain Metastases. Frontiers in Oncology. 12: 893264 |
Wefel JS, Ryan CJ, Van J, et al. (2022) Assessment and Management of Cognitive Function in Patients with Prostate Cancer Treated with Second-Generation Androgen Receptor Pathway Inhibitors. Cns Drugs. 36: 419-449 |
Schagen SB, Tsvetkov AS, Compter A, et al. (2022) Cognitive adverse effects of chemotherapy and immunotherapy: are interventions within reach? Nature Reviews. Neurology |
Parsons MW, Peters KB, Floyd SR, et al. (2021) Preservation of neurocognitive function in the treatment of brain metastases. Neuro-Oncology Advances. 3: v96-v107 |
Wefel JS, Zhou R, Sulman EP, et al. (2021) Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients. Journal of Neuro-Oncology |
Noll K, King AL, Dirven L, et al. (2021) Neurocognition and Health-Related Quality of Life Among Patients with Brain Tumors. Hematology/Oncology Clinics of North America. 36: 269-282 |